Cargando…
Knockout of ENO1 leads to metabolism reprogramming and tumor retardation in pancreatic cancer
The shift in glucose utilization from oxidative phosphorylation to glycolysis is the hallmark of tumor cells. The overexpression of ENO1, one of the key enzymes in the glycolysis process, has been identified in several cancers, however, its role in pancreatic cancer (PC) is yet unclear. This study i...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950624/ https://www.ncbi.nlm.nih.gov/pubmed/36845730 http://dx.doi.org/10.3389/fonc.2023.1119886 |